Xarelto

NDC 50458-575 · Janssen Pharmaceuticals, Inc.

Generic namerivaroxaban

Dosage formGRANULE, FOR SUSPENSION

RouteORAL

Active ingredient(s)RIVAROXABAN

Strength155 mg/1

Pharmacologic classFactor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]

Marketing categoryNDA

Packages

50458-575-01 — 1 BOTTLE in 1 CARTON (50458-575-01) / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE

FDA lists these products with the same active ingredient.

43598-981 — Rivaroxaban, 46708-346 — RIVAROXABAN, 46708-347 — RIVAROXABAN, 46708-348 — RIVAROXABAN, 46708-683 — RIVAROXABAN, 50090-3625 — rivaroxaban, 50090-3639 — rivaroxaban, 50090-4468 — rivaroxaban, 50090-4469 — rivaroxaban, 50228-513 — Rivaroxaban, 50458-577 — rivaroxaban, 50458-578 — rivaroxaban, 50458-579 — rivaroxaban, 50458-580 — rivaroxaban, 51672-4228 — Rivaroxaban, 55154-1422 — rivaroxaban, 55154-1423 — rivaroxaban, 55154-1424 — rivaroxaban, 55488-0540 — rivaroxaban, 55488-0541 — rivaroxaban, +23 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.